AHA 2015 Schedule
Jump to navigation
Jump to search
Here is the page we will use to coordinate the TV events at AHA 2015. Open time slots are indicated below in red.
Filming Location: Hyatt Regency Orlando, 9801 International Dr, Orlando, FL 32819, U.S.A.
Click on Date for Detailed Schedule
Sunday, November 8, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
- Interviewee: Dr. Karen Alexander
- Topic: Angina and Quality of Life Following PCI With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial
- Embargo Lift: Tuesday, November 10, 2015 at 11:45 AM
11:30 AM
OPEN TIME SLOT
12:00 PM
- Interviewee: Dr. Mihai Gheorghiade
- Topic: Oral sGC Stimulator Vericiguat in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction - The SOluble guanylate Cyclase stimulatoR in heArT failurE patientS With REDUCED EF (SOCRATES-REDUCED) Study
- Embargo Lift: Sunday, November 8, 2015 at 4:13 PM
12:30 PM
OPEN TIME SLOT
1:00 PM
- Interviewee: Dr. Henning Bundgaard
- Topic: The-First-in-Man Randomized Trial of a β3-adrenoceptor Agonist in Chronic Heart Failure - the BEAT-HF Trial
- Embargo Lift: Wednesday, November 11, 2015 at 10:57 AM
1:30 PM
- Interviewee: Dr. Margaret Redfield
- Topic: Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction (NEAT-HFpEF)
- Embargo Lift: Sunday, November 8, 2015 at 4:04 PM
2:00 PM
- Interviewee: Dr. Michael Ong
- Topic: Remote Patient Management After Discharge of Hospitalized Heart Failure Patients: The Better Effectiveness After Transition - Heart Failure Study
- Embargo Lift: Sunday, November 8, 2015 at 4:22 PM
2:30 PM
- Interviewee: Dr. Bonnie Spring
- Topic: Clinical Trial of a Mobile Health Intervention for Simultaneous versus Sequential Diet and Activity Change
- Embargo Lift: Monday, November 9, 2015 at 11:13 AM
3:00 PM
- Interviewee: Dr. Iftikhar Kullo
- Topic: The Effect of Disclosing Genomic Risk of Coronary Heart Disease on Low-density Lipoprotein Cholesterol Levels: The Myocardial Infarction Genes (MI-GENES) Study
- Embargo Lift: Monday, November 9, 2015 at 11:22 AM
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
Monday, November 9, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
- Interviewee: Dr. Noel Bairey-Merz
- Topic: A Randomized, Placebo Controlled Trial of Late Na Channel Inhibition (ranolazine) in Coronary Microvascular Dysfunction (CMD): Impact on Angina and Myocardial Ischemia
- Embargo Lift: Wednesday, November 11, 2015 at 11:45 AM
9:30 AM
OPEN TIME SLOT
10:00 AM
- Interviewee: Dr. Robert Yeh
- Topic: Individualizing Treatment Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: An Analysis of the DAPT Study
- Embargo Lift: Tuesday, November 10, 2015 at 11:30 AM
10:30 AM
- Interviewee: Dr. Myeong-ki Hong
- Topic: Clinical Outcomes of Intravascular Ultrasound Guided Everolimus-Eluting Stents Implantation in Long Coronary Lesions
- Embargo Lift: Tuesday, November 10, 2015 at 11:00 AM
11:00 AM
OPEN TIME SLOT
11:30 AM
- Interviewee: Dr. Geeta Gulati, Dr. Siri Heck and Dr. Torbjørn Omland
- Topic: Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Primary Results of a Randomized, 2 x 2 Factorial, Placebo-Controlled, Double-Blind Clinical Trial
- Embargo Lift: Wednesday, November 11, 2015 at 11:09 AM
12:00 PM
- Interviewee: Dr. Basil Lewis
- Topic: AHA 2015 Wrap-Up in Hebrew
12:30 PM
- Interviewee: Dr. Douglas Mann
- Topic: One Year Follow-up Results From AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation With Algisyl-LVR in the Treatment of Heart Failure
- Embargo Lift: Wednesday, November 11, 2015 at 10:45 AM
1:00 PM
- Interviewee: Dr. Valentin Fuster
- Topic: Impact of a Comprehensive Lifestyle Peer-group-based Intervention on Cardiovascular Risk Factors: A Randomized Controlled Trial
- Embargo Lift: Monday, November 9, 2015 at 11:04 AM
1:30 PM
- Interviewee: Dr. Justin Ezekowitz and Dr. Robert Welsh
- Topic: Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT-4)
- Embargo Lift: Tuesday, November 10, 2015 at 10:45 AM
2:00 PM
- Interviewee: Dr. Mark Eisenberg
- Topic: The Efficacy and Safety of Varenicline, a Selective Alpha4beta2 Nicotinic Receptor Partial Agonist, for Smoking Cessation in Patients Hospitalized With Acute Coronary Syndrome: A Randomized Controlled Trial
- Embargo Lift: Monday, November 9, 2015 at 10:55 AM
2:30 PM
- Interviewee: Dr. Lars Wallentin
- Topic: AHA 2015 Wrap-Up from a Scandinavian Perspective
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
Tuesday, November 10, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
- Interviewee: Dr. Paul Whelton
- Topic: Systolic Blood Pressure Intervention Trial (SPRINT)
- Embargo Lift: Monday, November 9, 2015 at 2:05 PM
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
- Interviewee: Dr. Marc Bonaca
- Topic: Long-Term Tolerability of Ticagrelor in the PEGASUS-TIMI 54 Trial
- Embargo Lift: Tuesday, November 10, 2015 at 11:15 AM
1:30 PM
- Interviewee: Dr. Freek Verheugt
- Topic: AHA 2015 Wrap-Up from a Perspective of the Netherlands
2:00 PM
- Interviewee: Dr. Renato Lopes
- Topic: AHA 2015 Wrap-Up in Portuguese
2:30 PM
- Interviewee: Dr. Myeong-ki Hong
- Topic: Clinical Outcomes of Intravascular Ultrasound Guided Everolimus-Eluting Stents Implantation in Long Coronary Lesions
- Embargo Lift: Tuesday, November 10, 2015 at 11:00 AM
3:00 PM
- Interviewee: Dr. Kenneth Margulies
- Topic: A Randomized Trial of Liraglutide for High-Risk Heart Failure Patients With Reduced Ejection Fraction
- Embargo Lift: Sunday, November 8, 2015 at 3:55 PM
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
- Interviewee: Dr. Kevin Fitzgerald
- Topic: ALN-PCSsc, an RNAi Investigational Agent That Inhibits PCSK9 With Potential for Effective Quarterly or Possibly Bi-Annual Dosing: Results of Single-Blind, Placebo-Controlled, Phase 1 Single-Ascending Dose (SAD), and Multi-Dose (MD) Trial in Adults With Elevated LDL-C, on and off Statins
- Embargo Lift: Wednesday, November 11, 2015 at 11:57 AM
4:45 PM
- Interviewee: Prof. Dr. Sigmund Silber
- Topic: AHA 2015 Wrap-Up in German
Wednesday, November 11, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
- Interviewee: Pr. Harvey White
- Topic: AHA 2015 Wrap-Up from a Pacific Rim Perspective
10:00 AM
- Interviewee: Dr. Hisao Ogawa
- Topic: AHA 2015 Wrap-Up in Japanese
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT